Eli Lilly has two press releases coming up next month, and considering the stability of this company, this could probably the easiest 10-20% you've ever made. The first press release is a phase 2 trial update for their drug, Donanemab (TRAILBLAZER-ALZ) for Alzheimer's. The second release is a meeting to schedule a PDUFA approval on the 24th. I will be selling after this meeting. Good Luck!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.